174 related articles for article (PubMed ID: 26330543)
1. Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study.
Duhamel M; Rodet F; Delhem N; Vanden Abeele F; Kobeissy F; Nataf S; Pays L; Desjardins R; Gagnon H; Wisztorski M; Fournier I; Day R; Salzet M
Mol Cell Proteomics; 2015 Nov; 14(11):2857-77. PubMed ID: 26330543
[TBL] [Abstract][Full Text] [Related]
2. Deciphering molecular consequences of the proprotein convertase 1/3 inhibition in macrophages for application in anti-tumour immunotherapy.
Rodet F; Capuz A; Hara T; van Meel R; Duhamel M; Rose M; Raffo-Romero A; Fournier I; Salzet M
J Biotechnol; 2018 Sep; 282():80-85. PubMed ID: 29990570
[TBL] [Abstract][Full Text] [Related]
3. Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion.
Gagnon H; Refaie S; Gagnon S; Desjardins R; Salzet M; Day R
PLoS One; 2013; 8(4):e61557. PubMed ID: 23637853
[TBL] [Abstract][Full Text] [Related]
4. The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways.
Duhamel M; Rodet F; Murgoci AN; Desjardins R; Gagnon H; Wisztorski M; Fournier I; Day R; Salzet M
Sci Rep; 2016 Jan; 6():19360. PubMed ID: 26778167
[TBL] [Abstract][Full Text] [Related]
5. Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion.
Refaie S; Gagnon S; Gagnon H; Desjardins R; D'Anjou F; D'Orléans-Juste P; Zhu X; Steiner DF; Seidah NG; Lazure C; Salzet M; Day R
J Biol Chem; 2012 Apr; 287(18):14703-17. PubMed ID: 22396549
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.
Duhamel M; Rose M; Rodet F; Murgoci AN; Zografidou L; Régnier-Vigouroux A; Vanden Abeele F; Kobeissy F; Nataf S; Pays L; Wisztorski M; Cizkova D; Fournier I; Salzet M
Mol Cell Proteomics; 2018 Jun; 17(6):1126-1143. PubMed ID: 29531019
[TBL] [Abstract][Full Text] [Related]
7. Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.
Murphy MB; Xiong Y; Pattabiraman G; Manavalan TT; Qiu F; Medvedev AE
J Leukoc Biol; 2015 Dec; 98(6):963-74. PubMed ID: 26310831
[TBL] [Abstract][Full Text] [Related]
8. The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages.
Tan Z; Xie N; Banerjee S; Cui H; Fu M; Thannickal VJ; Liu G
J Biol Chem; 2015 Jan; 290(1):46-55. PubMed ID: 25406319
[TBL] [Abstract][Full Text] [Related]
9. Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome.
Zhang ZQ; Wang J; Hoy Z; Keegan A; Bhagwat S; Gigliotti F; Wright TW
Infect Immun; 2015 Dec; 83(12):4594-603. PubMed ID: 26371121
[TBL] [Abstract][Full Text] [Related]
10. The Role of Proprotein Convertases in the Regulation of the Function of Immune Cells in the Oncoimmune Response.
Rose M; Duhamel M; Rodet F; Salzet M
Front Immunol; 2021; 12():667850. PubMed ID: 33995401
[TBL] [Abstract][Full Text] [Related]
11. PC1/3 KD Macrophages Exhibit Resistance to the Inhibitory Effect of IL-10 and a Higher TLR4 Activation Rate, Leading to an Anti-Tumoral Phenotype.
Rodet F; Capuz A; Ozcan BA; Le Beillan R; Raffo-Romero A; Kobeissy F; Duhamel M; Salzet M
Cells; 2019 Nov; 8(12):. PubMed ID: 31766635
[TBL] [Abstract][Full Text] [Related]
12. Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1.
Gersuk GM; Razai LW; Marr KA
J Immunol Methods; 2008 Jan; 329(1-2):157-66. PubMed ID: 17997408
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide mediated regulation of neuroendocrine associated proprotein convertases and neuropeptide precursor processing in the rat spleen.
Lansac G; Dong W; Dubois CM; Benlarbi N; Afonso C; Fournier I; Salzet M; Day R
J Neuroimmunol; 2006 Feb; 171(1-2):57-71. PubMed ID: 16337011
[TBL] [Abstract][Full Text] [Related]
14. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.
Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF
J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634
[TBL] [Abstract][Full Text] [Related]
15. Direct effects of airborne PM2.5 exposure on macrophage polarizations.
Zhao Q; Chen H; Yang T; Rui W; Liu F; Zhang F; Zhao Y; Ding W
Biochim Biophys Acta; 2016 Dec; 1860(12):2835-43. PubMed ID: 27041089
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of Pdcd4 results in induction of proprotein convertase 1/3 and potent secretion of chromogranin A and secretogranin II in a neuroendocrine cell line.
Lankat-Buttgereit B; Müller S; Schmidt H; Parhofer KG; Gress TM; Göke R
Biol Cell; 2008 Dec; 100(12):703-15. PubMed ID: 18549351
[TBL] [Abstract][Full Text] [Related]
17. Proprotein convertase 1/3 inhibited macrophages: A novel therapeutic based on drone macrophages.
Duhamel M; Rodet F; Murgoci A; Wisztorski M; Day R; Fournier I; Salzet M
EuPA Open Proteom; 2016 Jun; 11():20-22. PubMed ID: 29900108
[TBL] [Abstract][Full Text] [Related]
18. Toll-Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells.
Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Liu E; Peter K; Tipping P; Toh BH; Bobik A; Kyaw T
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27930350
[TBL] [Abstract][Full Text] [Related]
19. An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.
Tsukamoto H; Kubota K; Shichiku A; Maekawa M; Mano N; Yagita H; Ohta S; Tomioka Y
Immunology; 2019 Oct; 158(2):136-149. PubMed ID: 31515801
[TBL] [Abstract][Full Text] [Related]
20. Improved Chemotherapeutic Activity by Morus alba Fruits through Immune Response of Toll-Like Receptor 4.
Chang BY; Kim SB; Lee MK; Park H; Kim SY
Int J Mol Sci; 2015 Oct; 16(10):24139-58. PubMed ID: 26473845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
